Norgalax (Docusate Sodium)

Docusate sodium reduces the surface tension of the fecal mass, allowing water and fatty acids to penetrate the stool. This increases moisture content, softens the stool, and facilitates its passage without stimulating intestinal muscle contractions.

The appropriate dose of Norgalax is determined by the prescribing healthcare professional based on the patient’s condition, age, and response to therapy. Dosage instructions are provided on the prescription label.

Safety data for docusate sodium during pregnancy and lactation are limited. Use Norgalax only if the potential benefit justifies any possible risk, and discuss it with a qualified healthcare provider before starting treatment.

To order Norgalax, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Norgalax (docusate sodium) is a stool softener that works by surfactant action, whereas stimulant laxatives such as bisacodyl act by increasing intestinal motility. Docusate is generally gentler and less likely to cause cramping, making it suitable for mild to moderate constipation.

Store Norgalax at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from moisture, direct sunlight and extreme temperatures to maintain product stability.

Norgalax is supplied as a rectal preparation. It is inserted into the rectum according to the prescriber’s instructions, allowing the surfactant to act locally on the stool to improve softness and ease of passage.

Serious risks, although rare, include allergic reactions such as rash, swelling or itching, severe abdominal pain, and rectal bleeding. Patients should seek immediate medical attention if any of these symptoms occur.

Norgalax should be avoided in individuals with known hypersensitivity to docusate sodium, in patients with intestinal obstruction, severe colitis, or acute abdominal conditions, and in children unless specifically directed by a healthcare professional.